BRAIN Biotech AG (LON:0RFI)

London · Delayed Price · Currency is GBP · Price in EUR

2.890

+0.160 (5.86%)

At close: Jul 20, 2026

47.07% (1Y)

Market Cap	51.29M +39.9%
Revenue (ttm)	42.18M -9.7%
Net Income	-9.62M
EPS	-0.45
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Open	2.830
Previous Close	2.730
Day's Range	2.830 - 2.960
52-Week Range	1.900 - 3.900
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry. The company offers enzymes, biocatalysts, microorganisms, and other bio... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1993

Employees 280

Stock Exchange London Stock Exchange

Ticker Symbol 0RFI

Financial Performance

In fiscal year 2025, BRAIN Biotech AG's revenue was 50.22 million, a decrease of -9.52% compared to the previous year's 55.50 million. Losses were -11.74 million, 5.53% more than in 2024.

Financial numbers in EUR Financial Statements